This study aimed to assess the prognostic relevance of soluble serum PD-L1 in upper tract urothelial carcinoma (UTUC) patients who underwent surgical or systemic (chemo- or immune checkpoint inhibitor) therapy. This evidence concerns the gene CD274 and renal pelvis/ureter urothelial carcinoma.